For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

"Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people each year. It is associated with significantly poorer outcomes than drug-susceptible TB," said ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

A third drug, pretomanid, received emergency authorization from ... Oral regimens for rifampin-resistant, ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Shorter ...

Drug-susceptibility testing for bedaquiline ... or the initiation of new treatment for rifampin-resistant tuberculosis (for the full list of unfavorable outcomes, see Section 2.6.2 in the ...

In the next 5 years, it is expected that the application of molecular assays for the rapid detection of MDR-TB will increase ... for DST of all second-line drugs and also for the identification ...